Pieter H.A. Wisse

Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test–Based Screening

Pieter H.A. Wisse, Nicole S. Erler, Sybrand Y. de Boer et al. · Annals of Internal Medicine · 2022 · 65 citations · Full text

Medicine, Biostatistics, Oncology +17

The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic

Tim Kortlever, Lucie de Jonge, Pieter H.A. Wisse et al. · Preventive Medicine · 2021 · 45 citations · Full text

Medicine, Oncology, Preventive Medicine +17

Clinical Validation of a Multitarget Fecal Immunochemical Test for Colorectal Cancer Screening

Willemijn de Klaver, Pieter H.A. Wisse, Francine van Wifferen et al. · Annals of Internal Medicine · 2021 · 35 citations · Full text

Medicine, Oncology, Cancer Screening +16

Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program

Pieter H.A. Wisse, Sybrand Y. de Boer, Marco Oudkerk Pool et al. · Endoscopy · 2023 · 19 citations · Full text

Medicine, Oncology, Cancer Prevention +14

The multitarget faecal immunochemical test for improving stool-based colorectal cancer screening programmes: a Dutch population-based, paired-design, intervention study

Pieter H.A. Wisse, Willemijn de Klaver, Francine van Wifferen et al. · The Lancet Oncology · 2024 · 16 citations · Full text

Medicine, Oncology, Preventive Medicine +12